Daniel Chafetz, NP
Psychiatric/Mental Health · Tucson, AZNPI 1932130887
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,003 of the $18,206 with a category attached, or 87.9%. It is spread thinly across 35 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 849 payments — averaging $21.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$4K
- AbbVie$3K
- Neuronetics, Inc.$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Alkermes, Inc.$1K
- plus $5K from 29 others
What the payments were for
- Consulting fees$1,4008%
- Travel & lodging$7074%
- Food & beverage$16,00388%
- Education$971%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 144 | $3,547 |
| AbbVie(2 entities) | 179 | $3,145 |
| Neuronetics, Inc. | 11 | $1,854 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 80 | $1,477 |
| Teva Pharmaceuticals USA, Inc. | 83 | $1,444 |
| Alkermes, Inc. | 66 | $1,300 |
| Vanda Pharmaceuticals Inc. | 54 | $1,003 |
| Almatica Pharma LLC | 35 | $578 |
| Johnson & Johnson | 21 | $554 |
| Sunovion Pharmaceuticals Inc. | 24 | $456 |
| Bausch Health US, LLC | 24 | $399 |
| Indivior Inc. | 16 | $312 |
| E.r. Squibb & Sons, L.L.C. | 16 | $259 |
| Supernus Pharmaceuticals, Inc. | 11 | $247 |
| Harmony Biosciences LLC | 8 | $208 |
| Lundbeck LLC | 9 | $159 |
| Axsome Therapeutics, Inc. | 7 | $155 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $146 |
| Pfizer | 9 | $145 |
| Avanir Pharmaceuticals, Inc. | 7 | $107 |
| Alfasigma USA, Inc. | 6 | $102 |
| Neurocrine Biosciences, Inc. | 3 | $101 |
| Amgen | 4 | $96 |
| Corium, LLC | 3 | $78 |
| Novartis | 3 | $64 |
| Idorsia Pharmaceuticals US Inc | 4 | $61 |
| Eisai Inc. | 3 | $48 |
| Merck | 2 | $36 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $25 |
| Braeburn Inc. | 1 | $22 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Adlon Therapeutics L.p. | 1 | $12 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$1,654
- ABILIFY MYCITE$1,400
- LYBALVI$1,000
- VRAYLAR$371
- REXULTI$125
How this compares
$18,206 in reported general payments places this provider in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 62 | $341,502 |
| SpravatoEsketamine Hcl | 186 | $225,807 |
| VraylarCariprazine Hcl | 22 | $48,597 |
| NuedextaDextromethorphan Hbr/Quinidine | 13 | $21,034 |
| BelsomraSuvorexant | 38 | $16,930 |
| AuvelityDextromethorphan Hbr/Bupropion | 12 | $14,155 |
| ConcertaMethylphenidate Hcl | 12 | $11,198 |
| SunosiSolriamfetol Hcl | 12 | $10,488 |
| VyvanseLisdexamfetamine Dimesylate | 13 | $6,330 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 90 | $3,287 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 45 | $2,743 |
| Eszopiclone | 40 | $2,621 |
| Vilazodone Hcl | 36 | $2,271 |
| Aripiprazole | 74 | $2,148 |
| Alprazolam | 124 | $1,646 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $1,444 | $341,50262 claims |
| Johnson & JohnsonSpravato, Concerta | $554 | $237,005198 claims |
| AbbVieVraylar | $3,145 | $48,59722 claims |
| Axsome Therapeutics, Inc.Auvelity, Sunosi | $155 | $24,64324 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $107 | $21,03413 claims |
| MerckBelsomra | $36 | $16,93038 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $146 | $6,33013 claims |
| Almatica Pharma LLCSertraline Hcl | $578 | $69382 claims |
| Lilly USA, LLCOlanzapine | $14 | $36017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,230 psychiatric/mental health providers in Arizona.
Other psychiatric/mental health in Tucson
- Aaron del PinoTucson$28K
- Tabitha SalzerTucson$20K
- John EkmanTucson$13K
- Cassandra Diaz de LeonTucson$10K
- Sylvia ValenzuelaTucson$9K
- Toyin MarcusTucson$8K
- Isabella WaszkiewiczTucson$8K
- Melanie MartinTucson$7K
- Justine ConfinoTucson$5K
- Elizabeth ElliottPhoenix$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.